Humacyte (HUMA) Non-Current Assets (2020 - 2026)

Humacyte (HUMA) has reported Non-Current Assets for 7 consecutive years, with $45.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 47.97% year-over-year to $45.3 million in Q2 2026; TTM through Jun 2026 was $191.0 million, a 46.6% decrease from a year earlier, with the FY2025 full-year figure at $48.6 million, down 46.04% from the prior year.
• Non-Current Assets was $45.3 million for Q2 2026 at Humacyte, down from $47.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $91.8 million in Q3 2024 and troughed at $42.2 million in Q2 2024.
• A 5-year average of $57.4 million and a median of $49.6 million in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 106.46% in 2025 and plunged 47.97% in 2026, its largest moves.
• Over 5 years, Non-Current Assets stood at $50.1 million in 2022, then fell by 10.28% to $44.9 million in 2023, then surged by 100.27% to $90.0 million in 2024, then sank by 46.04% to $48.6 million in 2025, then dropped by 6.73% to $45.3 million in 2026.
• The last three Non-Current Assets figures came in at $45.3 million (Q2 2026), $47.0 million (Q1 2026), and $48.6 million (Q4 2025), per Business Quant data.